Blue Granite Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Blue Granite Capital's MRK Position: Q4 2017 in Review
Blue Granite Capital reduced its Merck (MRK) stake by 56% in Q4 2017, selling an estimated $881K and leaving 12,445 shares worth $669K. The position accounts for 0.49% of the portfolio, ranked #27.
Blue Granite Capital first reported a position in MRK in Q4 2016 and has held it in 5 quarters since. The position peaked at $2.86M in Q2 2017. 2,008 funds tracked by Wall St. Rank hold MRK as of Q4 2017.
- Blue Granite Capital held 12,445 shares of Merck worth $669K as of Q4 2017.
- Blue Granite Capital sold 15,893 Merck shares in Q4 2017, an estimated $881K.
- Merck made up 0.49% of Blue Granite Capital's portfolio in Q4 2017, its #27 holding.
- Blue Granite Capital first reported a position in Merck in Q4 2016 and has held it in 5 quarters since.
- Blue Granite Capital's Merck position peaked at $2.86M in Q2 2017.
- 2,008 funds tracked by Wall St. Rank held Merck as of Q4 2017.
Based on Blue Granite Capital's 13F filing for Q4 2017, filed 14 Feb 2018.